Dec 16 (Reuters) - Cellectar Biosciences Inc CLRB.O:
CELLECTAR BIOSCIENCES ANNOUNCES STRATEGIC SUPPLY AGREEMENT WITH IONETIX FOR ACTINIUM-225 AND ASTATINE-211 TO ADVANCE TARGETED ALPHA THERAPIES
CELLECTAR BIOSCIENCES INC - ANNOUNCES MULTI-YEAR SUPPLY AGREEMENT WITH IONETIX
Source text: ID:nGNX4Mx7G6
Further company coverage: CLRB.O
((Reuters.Briefs@thomsonreuters.com;))